SCLC


Ongoing protocols: click on the protocol for the inclusion and exclusion criteria (update 15/11/2019)
 

Non-metastatic stage

Currently no trials

Metastatic stage

1st line

Currently no trials

2nd line
Currently no trials

3th line
JZHB (Lilly)
A phase 1b study of LY3295668 Erbumine Monotherapy in Patients With Platinum-Sensitive, Extenstive-Stage SCLC.